Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Liberty Media Corp
13G/A
LLYVA · 531229748
|
4.6% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 4.6% | ||||
| Point72 Capital Advisors, Inc. | 4.6% | ||||
| Steven A. Cohen | 4.6% | ||||
|
Syros Pharmaceuticals, Inc.
13G/A
SYRS · 87184Q206
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Inhibikase Therapeutics, Inc.
13G/A
IKT · 45719W205
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Avid Bioservices, Inc.
13G/A
CDMO · 05368M106
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Rapid7, Inc.
13G/A
RPD · 753422104
|
2.4% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 2.4% | ||||
| Point72 Capital Advisors, Inc. | 2.4% | ||||
| Steven A. Cohen | 2.4% | ||||
|
Bright Minds Biosciences Inc.
13G/A
DRUG · 10919W405
|
3.0% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 3.0% | ||||
| Point72 Capital Advisors, Inc. | 3.0% | ||||
| Steven A. Cohen | 3.0% | ||||